HomeSONN • NASDAQ
add
Sonnet BioTherapeutics Holdings, Inc.
Previous close
$1.55
Day range
$1.51 - $1.61
Year range
$1.41 - $18.72
Market cap
4.75M USD
Avg Volume
1.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 7.60M | -43.64% |
Net income | -3.13M | 14.91% |
Net profit margin | — | — |
Earnings per share | -10.39 | 92.48% |
EBITDA | -3.17M | 11.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.46K | -93.43% |
Total assets | 2.77M | -48.96% |
Total liabilities | 3.26M | -42.41% |
Total equity | -485.74K | — |
Shares outstanding | 3.01M | — |
Price to book | -2.07 | — |
Return on assets | -185.19% | — |
Return on capital | -657.44% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.13M | 14.91% |
Cash from operations | -3.17M | 30.47% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -234.70K | -1,226.09% |
Net change in cash | -3.40M | 28.27% |
Free cash flow | -2.20M | 30.12% |
About
Founded
1999
Headquarters
Website
Employees
13
